Efficacy of individualized homoeopathic medicines in the treatment of tinea corporis in adults: A double-blind, randomized, placebo-controlled trial.

Superficial mycotic infections affect approximately 20–25% of the global population, with dermatophytes being the most common causative agents. Tinea is characterized by slow-growing lesions that frequently have some central clearance (ring-like). In certain people, the fungus causes virtually minimal inflammation; in these patients, the infection manifests as a marginated area of rough, scaling skin. Treatment typically involves topical antifungals for mild cases, while more extensive infections often require systemic therapy. In recent years, chronic dermatophyte infections have become increasingly common and challenging to treat. However, the absence of updated national or international guidelines for managing tinea corporis, tinea cruris, and tinea pedis has led to largely empirical systemic antifungal treatments [3]. Homeopathy may have immense potential to offer in the successful treatment of tinea corporis, but concrete data is not available for this claim. Under such circumstances, we intend to undertake this research project to evaluate the Efficacy of individualized homoeopathic medicines in the treatment of tinea corporis in adults. A double-blind, randomized (2:1), placebo-controlled trial will be conducted on 108 adults who are suffering from tinea corporis at the outpatient department of D. N. De Homoeopathic Medical College and Hospital. Assessment will be done by the Skindex-29 questionnaire [Primary outcomes], 5-D pruritus scale, and MYMOP-2 (Measure Yourself Medical Outcome Profile) [Secondary outcomes] every month up to 2 months. Comparative analysis will be carried out to detect group differences.